Han Chang
About Han Chang
Han Chang is the Senior Director and Head of Late Stage Oncology, Translational Bioinformatics at Bristol Myers Squibb, with a Ph.D. from Harvard University and extensive experience in oncology research and bioinformatics.
Company
Han Chang is currently working at Bristol Myers Squibb as the Senior Director, Head of Late Stage Oncology, Translational Bioinformatics. His role involves advancing late-stage oncology programs through innovative bioinformatics strategies. Bristol Myers Squibb is known for its significant contributions in oncology research, and Han's work is integral to their ongoing projects in this area.
Title
Han Chang holds the position of Senior Director, Head of Late Stage Oncology, Translational Bioinformatics at Bristol Myers Squibb. In this capacity, he oversees the integration of advanced bioinformatics techniques into oncology research to enhance the precision of therapeutic interventions for cancer patients.
Education and Expertise
Han Chang has a diverse and multidisciplinary educational background. He earned his Bachelor of Science in Astrophysics from Peking University. He further pursued a Ph.D. in Biophysics, Molecular and Cellular Biology from Harvard University. Additionally, he completed a Postdoctoral Fellowship at Stanford University School of Medicine in neurobiology, bioinformatics, molecular biology, and molecular genetics. His expertise lies in translational bioinformatics, particularly in oncology research, utilizing advanced data analytics and machine learning to innovate cancer treatment.
Background
Han Chang has been with Bristol Myers Squibb for several years, starting as a Bioinformatics Liaison for Immuno-science R&D from 1998 to 2007, and then as a Bioinformatics Lead for Oncology R&D from 2008 to 2014 in Hopewell, NJ. His extensive experience spans various roles, focusing on integrating bioinformatics with oncology and immuno-science research. He has been instrumental in building multidisciplinary teams and fostering collaborations between academic institutions and industry partners.
Achievements
Han Chang has led the integration of multi-dimensional datasets to identify novel biomarkers for patient stratification in oncology. His efforts have been critical in advancing late-stage oncology programs at Bristol Myers Squibb. He has played a key role in developing translational bioinformatics strategies and has significant experience in managing collaborations to drive forward oncology research. Furthermore, Han has successfully applied machine learning and AI techniques to address complex problems in cancer genomics, contributing to personalized treatments and optimizing clinical trial designs.